Assessment of Dermatological Manifestations of HIV in Primary Care
Life Sciences-Medicine
DOI:
https://doi.org/10.22376/ijlpr.2023.13.1.SP2.L1-L11Keywords:
HIV, Dermatology, Immunity, Skin, Autoimmune Disease, HIV/AIDSAbstract
Abstract: HIV infection continues to be a significant problem. Infected patients with HIV/AIDS were the first to show skin infections in the 1980s. It was projected that 35 million individuals would be infected with the Human Immunodeficiency Virus (HIV) in 2013. Before illnesses like diabetes and COPD, skin disorders were considered the 4th most common non-fatal disease burden globally in terms of years lost owing to disability. HIV-related skin disorders have a significant burden on society, have an adverse effect on the quality of life, and are directly linked to death. Pathophysiology of the disease is based mainly on understanding the pathology of the skin's immune system, as CD4 lymphocytes are considered the main key to the immunological response of the dermis and serve to inhibit autoimmune diseases and control infections. Hence, a massive decline is noticed in CD4 lymphocytes in patients diagnosed with HIV/AIDS, as mostly CD4 counts below 200 cells per cubic millimetre, which reveals the absence of immunity in the patients Because HIV-related skin problems are challenging to manage and might even reoccur more frequently than in immunocompetent people in the absence of immunological reconstitution with cART, managing them effectively presents unique challenges. Early detection of skin problems linked to HIV offers the chance for early HIV identification and cART introduction, potentially improving overall survivability. Additionally, in environments with low resources, attention is brought to opportunistic infections that are more likely to be fatal, and skin disorders may go unnoticed. This review aims to summarise current knowledge of pathophysiology, causes, and treatment of HIV-related skin disorders with the objective of more qualitative resources for further research, which contributes to better understanding and reveals the points that need further research. Keywords:,,,, ,
References
Rajeev A, Fuller C. Cutaneous manifestations of human immunodeficiency virus infection. Dermatol Nurs. 2011;10:12-7.
UNAIDS. The Gap report. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS. Gap report en.pdf; 2014.
Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc. 2011;14:5. doi: 10.1186/1758-2652-14-5, PMID 21261982.
Rodgers S, Leslie KS. Skin infections in HIV-infected individuals in the era of HAART. Curr Opin Infect Dis. 2011;24(2):124-9. doi: 10.1097/QCO.0b013e328342cb31, PMID 21169832.
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ et al. The global burdenof skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527-34. doi: 10.1038/jid.2013.446, PMID 24166134.
Tschachler E, Bergstresser PR, Stingl G. HIV-related skin diseases. Lancet. 1996;348(9028):659-63. doi: 10.1016/S0140-6736(96)01032-X, PMID 8782758.
Bosamiya SS, Vaishnani JB, Momin AM. Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy. Indian J Sex Transm Dis AIDS. 2014;35(1):73-5. doi: 10.4103/0253-7184.132412, PMID 24958996.
Balighi K, Soori T, Fouladi N. Mucocutaneous manifestations as the first presentations of HIV infection. Iran J Dermatol. 2013;16:105-8.
Altuntaş Aydin Ö, Kumbasar Karaosmanoğlu H, Korkusuz R, Özeren M, Özcan N. Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among Turkish HIV/AIDS patients in Istanbul, Turkey. Turk J Med Sci. 2015;45(1):89-92. doi: 10.3906/sag-1308-3, PMID 25790535.
Bartlett JG, Gallant JE. Medical management of HIV infection 2004.
Garman ME, Tyring SK. The cutaneous manifestations of HIV infection. Dermatol Clin. 2002;20(2):193-208. doi: 10.1016/s0733-8635(01)00011-0, PMID 12120434.
Lowe S, Ferrand RA, Morris-Jones R, Salisbury J, Mangeya N, Dimairo M et al. Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection. Pediatr Infect Dis J. 2010;29(4):346-51. doi: 10.1097/INF.0b013e3181c15da4, PMID 19940800.
Hay R, Bendeck SE, Chen S et al., chapter 37, The International Bank for Reconstruction and Development/The World Bank Group,Washington. Skin diseases. In: Jamison T, Breman JG, Measham AR et al., editors. DiseaseControl priorities inDevelopingCountries,D. DC; 2006.
Richmond JM, Harris JE. Immunology and skin in health and disease. Cold Spring Harb Perspect Med. 2014;4(12):a015339. doi: 10.1101/cshperspect.a015339, PMID 25452424.
Dybull M, Connors M, Fauci A. The Immunology of human immunodeficiency virus. In: Khambaty M, Hsu S, editors: Dermatology of the patient with HIV. Emerg Med Clin North Am 28. Mandell, Douglas and Bennett’s principles and practice of infectious diseases. 6th ed. Publisher Elsevier. Philadelphia: Churchill Livingstone; 2010. p. 355-68.
Bolognia J, Jorizzo J, Schaffer. J Dermatol. 2012;3.
Bjekić M, Šipetić S. Skin diseases and sexually transmitted infections among patients with HIV infection/AIDS referred at the city institute for skin and venereal diseases in Belgrade: a case series of 38 patients. Serb J Dermatol Venerol. 2013;5(3):125-30. doi: 10.2478/sjdv-2013-0010.
Singh N, Yadav N, Kar S, Madke B, Prasad K, Chandekar P. Spectrum of skin disorders in human immunodeficiency virus-infected patients in a rural area of Maharashtra and the relation to CD4 lymphocyte counts. Health Agenda. 2014;4:120-4.
Amerson E, Maurer T. Dermatologic manifestations of HIV in Africa. Top HIV Med Publ Int AIDS Soc USA. 2009;18:16-22.
Mirmirani P, Hessol NA, Maurer TA, Berger TG, Nguyen P, Khalsa A, et al. Prevalence and predictors of skin disease in the Women’s Interagency HIV Study (WIHS). J Am Acad Dermatol. 2001;44(5):785-8. doi: 10.1067/mjd.2001.112350, PMID 11312425.
Kaushik SB, Cerci FB, Miracle J, Pokharel A, Chen SC, Chan YH, et al. Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life. J Am Acad Dermatol. 2014;70(4):659-64. This cross sectional study evaluates the most common skin complaints in patients in the US and their effect on the quality of life. doi: 10.1016/j.jaad.2013.12.015, PMID 24503217.
Friedler S, Parisi MT, Waldo E, Wieczorek R, Sidhu G, Rico MJ. Atypical cutaneous lymphoproliferative disorder in patients with HIV infection. Int J Dermatol. 1999;38(2):111-8. doi: 10.1046/j.1365-4362.1999.00417.x, PMID 10192159.
Szczech LA. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis. 2001;33(1):115-9. doi: 10.1086/320893, PMID 11389504.
Bonacini M. Pruritus in patients with chronic human immunodeficiency virus, hepatitis B and C virus infections. Dig Liver Dis. 2000;32(7):621-5. doi: 10.1016/s1590-8658(00)80847-6, PMID 11142563.
Prakash M, Poreddy V, Tiyyagura L, Bonacini M. Jaundice and hepatocellular damage associated with nevirapine therapy. Am J Gastroenterol. 2001;96(5):1571-4. doi: 10.1111/j.1572-0241.2001.03779.x, PMID 11374701.
Lambert M. Thyroid dysfunction in HIV infection. Baillieres Clin Endocrinol Metab. 1994;8(4):825-35. doi: 10.1016/s0950-351x(05)80303-9, PMID 7811224.
Gabarre J, Raphael M, Lepage E, Martin A, Oksenhendler E, Xerri L, et al. Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes. Am J Med. 2001;111(9):704-11. doi: 10.1016/s0002-9343(01)01020-8, PMID 11747850.
Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338(13):853-60. doi: 10.1056/NEJM199803263381301, PMID 9516219.
Handa S, Bingham JS. Dermatological immune restoration syndrome: does it exist? J Eur Acad Dermatol Venereol. 2001;15(5):430-2. doi: 10.1046/j.1468-3083.2001.00337.x, PMID 11763384.
Bachmeyer C, Cordier F, Cazier A, Blum L, Mougeot-Martin M. Eosinophilic folliculitis associated with AIDS after antiretroviral tri-therapy. Presse Med. 1999;28(40):2226. PMID 10636011.
Dermatologic manifestations of HIV in Africa – Scientific Figure on ResearchGate [cited Nov 23, 2022]. Available from: https://www.researchgate.net/figure/Papular-pruritic-eruption-of-HIV-Thickened-hyperpigmented-papules-of-less-than-1-cm_fig1_42372271.
Silverberg MJ, Leyden W, Warton EM, Quesenberry CP Jr, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013;105(5):350-60. This is a cohort study showing a higher risk of non-melanoma skin cancer in HIV patients. doi: 10.1093/jnci/djs529, PMID 23291375 Altman et al. Page Curr.
Grabar S, Abraham B, Mahamat A, Del Giudice P, Rosenthal E, Costagliola D. Differential impact of combination antiretroviral therapy in preventing Kaposi’s sarcoma with and without visceral involvement. J Clin Oncol. 2006;24(21):3408-14. doi: 10.1200/JCO.2005.05.4072, PMID 16849755.
Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, et al. Cancer incidence in people with AIDS in Italy. Int J Cancer. 2010;127(6):1437-45. doi: 10.1002/ijc.25153, PMID 20049835.
Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103(3):416-22. doi: 10.1038/sj.bjc.6605756, PMID 20588274.
Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illness in the era of antiretroviral combination therapy. AIDS. 1997;11(14):1731-8. doi: 10.1097/00002030-199714000-00010, PMID 9386808.
Tschachler E. Kaposi’s sarcoma. In: Fitzpatrick’s dermatology in general medicine. 7th ed. New Delhi: McGraw-Hill Company; 2008. p. 1183-7.
Marfatia Y, Bhagat U, Sharma A. Violaceous papulonodular lesions in an AIDS case. Indian J Sex Transm Dis. 2008;29(1):51-3. doi: 10.4103/0253-7184.42722.
Brodt HR, Kamps BS, Helm EB, Schofer H, Mitrou P. Kaposi’ sarcoma in HIV infection: impact on oppurtinistic infections and survival. AIDS. 1998;12:1275-84.
Shroff HJ, Dashatwar DR, Deshpande RP, Waigmann HR. AIDSassociated Kaposi’s sarcoma in an Indian female. J Assoc Physicians India. 1993;41(4):241-2. PMID 8270582.
Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Int J Dermatol. 2007;46;Suppl 2:14-8. doi: 10.1111/j.1365-4632.2007.03349.x, PMID 17958624.
Calonje E. Vascular tumors: tumors and tumor-like conditions of blood vessels and lymphatics. In: Lever’s histopathology of the skin. 10th ed. New-Delhi: Wolters Kluwer (India); 2010. p. 1007-56.
Von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med. 2001;344(1):11-6. doi: 10.1056/NEJM200101043440102, PMID 11136954.
Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol. 2008;29(6):510-6. doi: 10.1086/588201, PMID 18510460.
Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis. 2010;50(7):979-87. doi: 10.1086/651076, PMID 20192731.
Popovich KJ, Hota B, Aroutcheva A, Kurien L, Patel J, Lyles-Banks R, et al. Community-associated methicillin-resistant Staphylococcus aureus colonization burden in HIV-infected patients. Clin Infect Dis. 2013;56(8):1067-74. This study shows increased MRSA colonization burden in HIV patients and highlights associated risk factors. doi: 10.1093/cid/cit010, PMID 23325428.
Kazem S, van der Meijden E, Feltkamp MC. The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications. APMIS. 2013;121(8):770-82. doi: 10.1111/apm.12092, PMID 23593936.
Ehlers B, Wieland U. The novel human polyomaviruses HPyV6, 7, 9 and beyond. APMIS. 2013;121(8):783-95. doi: 10.1111/apm.12104, PMID 23656581.
Sharma YK, Sawhney M, Bhakuni DS, Gera V. Orocutaneous manifestations as markers of disease progression in HIV infection in Indian setting. Med J Armed Forces India. 2004;60(3):239-43. (PMC Free article). doi: 10.1016/S0377-1237(04)80054-6, PMID 27407641, Google Scholar.
Goh BK, Chan RK, Sen P, Theng CT, Tan HH, Wu YJ et al. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts. Int J Dermatol. 2007;46(7):695-9. doi: 10.1111/j.1365-4632.2007.03164.x, PMID 17614796, Google Scholar.
Mucocutaneous manifestations of HIV and the correlation with WHO clinical staging in a tertiary hospital in Nigeria. Oninla OA. AIDS Res Treat. 2014;2014:360970. (PMC Free article). PMID PubMed, Google Scholar.
Mawenzi RL, Oguttu OR, Williams HC, Joash A. Epidemiology and clinical spectrum of cutaneous diseases manifesting among newly diagnosed HIV seropositive adults in Nakuru County-Kenya. Contin J Med Res. 2013;7:1-9. Google Scholar.
Rogers HD, Macgregor JL, Nord KM, Tyring S, Rady P, Engler DE, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2009;60(2):315-20. doi: 10.1016/j.jaad.2008.08.035, PMID 19150275.
Vicente A, Pau-Charles I, González-Enseñat MA, Muñoz-Almagro C, Cañadas MP, Noguera-Julian A, et al. High-risk alpha-human papillomavirus types: detection in HIV-infected children with acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2013;68(2):343-5. doi: 10.1016/j.jaad.2012.08.026, PMID 23317976.
Dziuban EJ, Hughey AB, Stewart DA, Blank DA, Kochelani D, Draper HR, et al. Stevens-Johnson syndrome and HIV in children in Swaziland. Pediatr Infect Dis J. 2013;32(12):1354-8. doi: 10.1097/INF.0b013e31829ec8e5, PMID 23743542.
Saka B, Barro-Traoré F, Atadokpédé FA, Kobangue L, Niamba PA, Adégbidi H, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Int J Dermatol. 2013;52(5):575-9. doi: 10.1111/j.1365-4632.2012.05743.x, PMID 23330601.
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865-9. doi: 10.1126/science.7997879, PMID 7997879, Google Scholar.
Jakob L, Metzler G, Chen KM, Garbe C. Non-AIDS associated Kaposi’s sarcoma: clinical features and treatment outcome. PLOS ONE. 2011;6(4):e18397. doi: 10.1371/journal.pone.0018397, PMID 21533260. Bibcode. 2011PLoSO... 618397J. doi: 10.1371/journal.pone.0018397. ISSN 1932-6203. PMCID 3075253. PMID 21533260.
Dohil MA, Lin P, Lee J, Lucky AW, Paller AS, Eichenfield LF. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. 2006;54(1):47-54. doi: 10.1016/j.jaad.2005.08.035, PMID 16384754. [2]. Singh RV, Singh S, Pandey SS. Numerous giant mollusca contagiosa and kaposi's sarcomas with HIV disease. Indian J Dermatol Venereol Leprol. 1996;62(3):173-4. PMID 20948029.
Petersen CS, Gerstoft J. Molluscum contagiosum in HIV infected patients. Dermatology. 1992;184(1):19-21. [13] Thappa DM, Karthikeyan K, Manjunath JV. doi: 10.1159/000247492, PMID 1558989.
Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964-73. doi: 10.1001/jama.296.8.964, PMID 16926356.
Sbidian E, Battistella M, Legoff J, Lafaurie M, Bézier M, Agbalika F, et al. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy. Clin Infect Dis. 2013;57(11):1648-55. doi: 10.1093/cid/cit592, PMID 24065320.
Erdmann NB, Prentice HA, Bansal A, Wiener HW, Burkholder G, Shrestha S, et al. Herpes zoster in persons living with HIV-1 infection: viremia and immunological defects are strong risk factors in the era of combination antiretroviral therapy. Front Public Health. 2018;6:70. doi: 10.3389/fpubh.2018.00070, PMID 29594092.
Wallace MR, Hooper DG, Pyne JM, Graves SJ, Malone JL. Varicella immunity and clinical disease in HIV-infected adults. South Med J. 1994;87(1):74-6. doi: 10.1097/00007611-199401000-00016, PMID 8284723.
Weismann K, Knudsen EA, Pedersen C. White nails in AIDS/ARC due to Trichophyton rubrum infection. Clin Exp Dermatol. 1988;13(1):24-5. doi: 10.1111/j.1365-2230.1988.tb00643.x, PMID 2974764.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Najlaa Mohammad Alsudairy, Alnahari Nouran Ahmed A, Aletayani Hatun Nuwaymi M, Qahtani Saad Hussain A , Alahmadi Arwa Faisal, Abdullah Ali N Aljalfan, Altaymani Abdulaziz Talal A, Allihaibi Malak Mohammad E, Asiri Bahni Mohammed A , Maghrbi Ali Mohammed A, Mohammed Sulaiman Naif Alkathery, Bader Abdulwahab N Alamer, Alaklabi Mohammed Shari J, Rimah Omar A Alfawzan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
